Singapore markets closed

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
20.49-1.31 (-6.01%)
At close: 04:00PM EST
20.63 +0.14 (+0.68%)
After hours: 07:37PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 2.89B
Enterprise value 4.93B
Trailing P/E 29.90
Forward P/E 15.02
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.21
Price/book (mrq)1.45
Enterprise value/revenue 2.35
Enterprise value/EBITDA 10.19

Trading information

Stock price history

Beta (5Y monthly) 0.14
52-week change 3-45.36%
S&P500 52-week change 322.74%
52-week high 341.58
52-week low 318.24
50-day moving average 322.62
200-day moving average 325.18

Share statistics

Avg vol (3-month) 3878.65k
Avg vol (10-day) 3682.36k
Shares outstanding 5132.22M
Implied shares outstanding 687.93M
Float 873.91M
% held by insiders 127.42%
% held by institutions 161.25%
Shares short (30 Dec 2021) 47.11M
Short ratio (30 Dec 2021) 48.17
Short % of float (30 Dec 2021) 48.57%
Short % of shares outstanding (30 Dec 2021) 45.38%
Shares short (prior month 29 Nov 2021) 47.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 2.51%
Operating margin (ttm)11.25%

Management effectiveness

Return on assets (ttm)4.39%
Return on equity (ttm)3.63%

Income statement

Revenue (ttm)2.1B
Revenue per share (ttm)19.16
Quarterly revenue growth (yoy)129.70%
Gross profit (ttm)191.28M
EBITDA 441.24M
Net income avi to common (ttm)40.15M
Diluted EPS (ttm)-0.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)336.65M
Total cash per share (mrq)2.55
Total debt (mrq)2.39B
Total debt/equity (mrq)119.96
Current ratio (mrq)1.64
Book value per share (mrq)15.06

Cash flow statement

Operating cash flow (ttm)225.1M
Levered free cash flow (ttm)55.74M